Jean–Jacques Garaud
Publications by Year
Research Areas
Antimicrobial Resistance in Staphylococcus, Antibiotics Pharmacokinetics and Efficacy, Inflammation biomarkers and pathways, Bacterial Identification and Susceptibility Testing, Streptococcal Infections and Treatments
Most-Cited Works
- → Adherence to combination therapy enhances sustained response in genotype-1–infected patients with chronic hepatitis C(2002)977 cited
- → Evaluation of teicoplanin for treatment of endocarditis caused by gram-positive cocci in 20 patients(1989)77 cited
- → A multicentre open clinical trial of teicoplanin in infections caused by Gram-positive bacteria(1988)77 cited
- → sTREM-1 is a specific biomarker of TREM-1 pathway activation(2021)71 cited
- → Nangibotide in patients with septic shock: a Phase 2a randomized controlled clinical trial(2020)70 cited
- → Prospective evaluation of the efficacy, safety, and optimal biomarker enrichment strategy for nangibotide, a TREM-1 inhibitor, in patients with septic shock (ASTONISH): a double-blind, randomised, controlled, phase 2b trial(2023)65 cited
- → Cardiovascular safety of lumiracoxib: A meta-analysis of all randomized controlled trials ≥1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis(2005)54 cited
- → Renal disposition of gentamicin, dibekacin, tobramycin, netilmicin, and amikacin in humans(1985)52 cited
- → A first‐in‐man safety and pharmacokinetics study of nangibotide, a new modulator of innate immune response through TREM‐1 receptor inhibition(2018)44 cited
- → Vancomycin pharmacokinetics in critically ill patients(1984)44 cited